KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Amortization - Intangibles (2016 - 2025)

Charles River Laboratories International has reported Amortization - Intangibles over the past 17 years, most recently at $21.0 million for Q4 2025.

  • For Q4 2025, Amortization - Intangibles fell 49.09% year-over-year to $21.0 million; the TTM value through Dec 2025 reached $179.1 million, up 29.25%, while the annual FY2025 figure was $179.1 million, 29.31% up from the prior year.
  • Amortization - Intangibles for Q4 2025 was $21.0 million at Charles River Laboratories International, down from $27.4 million in the prior quarter.
  • Over five years, Amortization - Intangibles peaked at $65.4 million in Q2 2025 and troughed at $21.0 million in Q4 2025.
  • A 5-year average of $36.3 million and a median of $34.1 million in 2023 define the central range for Amortization - Intangibles.
  • On a YoY basis, Amortization - Intangibles climbed as much as 102.43% in 2025 and fell as far as 49.09% in 2025.
  • Year by year, Amortization - Intangibles stood at $30.2 million in 2021, then increased by 17.26% to $35.5 million in 2022, then decreased by 4.11% to $34.0 million in 2023, then increased by 21.33% to $41.3 million in 2024, then crashed by 49.09% to $21.0 million in 2025.
  • Business Quant data shows Amortization - Intangibles for CRL at $21.0 million in Q4 2025, $27.4 million in Q3 2025, and $65.4 million in Q2 2025.